APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Design

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Drug Design Market Analysis and Forecast 2026-2032

Report ID 17405740024 March 2026194 pages

Choose your research edition.

Industry ResearchAI Drug Design Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Design Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI Drug Design Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Design Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Design Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global AI Drug Design market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Drug Design is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Drug Design is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Drug Design is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Drug Design is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Drug Design include Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise and Envisagenics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Drug Design, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Drug Design, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Drug Design, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Drug Design revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Drug Design market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Drug Design revenue, projected growth trends, production technology, application and end-user industry.

AI Drug Design Segment by Company

Exscientia

PathAI

Tempus

Aria Pharmaceuticals

BenchSci

Antidote

AiCure

Atomwise

Envisagenics

Sherlock

Deep Genomics

Benevolent

Iktos

AlmirallShare

AI Drug Design Segment by Type

Therapy Research

Design and Development

Others

AI Drug Design Segment by Application

Cancer

Cardiovascular Disease

Others

AI Drug Design Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Design market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Design and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Design.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Drug Design in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Drug Design company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Design revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Design Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Therapy Research Major Player Table 3. Design and Development Major Player Table 4. Others Major Player Table 5. Global AI Drug Design Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cancer Major Player Table 7. Cardiovascular Disease Major Player Table 8. Others Major Player Table 9. AI Drug Design Industry Trends Table 10. AI Drug Design Industry Drivers Table 11. AI Drug Design Industry Opportunities and Challenges Table 12. AI Drug Design Industry Restraints Table 13. Global AI Drug Design Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI Drug Design Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI Drug Design Market Share by Region (2021-2026) Table 16. Global AI Drug Design Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI Drug Design Market Share by Region (2027-2032) Table 18. Global AI Drug Design Revenue by Players (US$ Million) & (2021-2026) Table 19. Global AI Drug Design Revenue Market Share by Players (2021-2026) Table 20. Global AI Drug Design Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global AI Drug Design Key Players Headquarters & Area Served Table 22. Global AI Drug Design Players, Product Type & Application Table 23. Global AI Drug Design Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global AI Drug Design by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global AI Drug Design Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Drug Design Revenue by Type (2021-2026) & (US$ Million) Table 28. Global AI Drug Design Revenue by Type (2027-2032) & (US$ Million) Table 29. Global AI Drug Design Revenue Market Share by Type (2021-2026) Table 30. Global AI Drug Design Revenue Market Share by Type (2027-2032) Table 31. Global AI Drug Design Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Drug Design Revenue by Application (2021-2026) & (US$ Million) Table 33. Global AI Drug Design Revenue by Application (2027-2032) & (US$ Million) Table 34. Global AI Drug Design Revenue Market Share by Application (2021-2026) Table 35. Global AI Drug Design Revenue Market Share by Application (2027-2032) Table 36. Exscientia Company Information Table 37. Exscientia Business Overview Table 38. Exscientia AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Exscientia AI Drug Design Product Portfolio Table 40. Exscientia Recent Development Table 41. PathAI Company Information Table 42. PathAI Business Overview Table 43. PathAI AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. PathAI AI Drug Design Product Portfolio Table 45. PathAI Recent Development Table 46. Tempus Company Information Table 47. Tempus Business Overview Table 48. Tempus AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Tempus AI Drug Design Product Portfolio Table 50. Tempus Recent Development Table 51. Aria Pharmaceuticals Company Information Table 52. Aria Pharmaceuticals Business Overview Table 53. Aria Pharmaceuticals AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Aria Pharmaceuticals AI Drug Design Product Portfolio Table 55. Aria Pharmaceuticals Recent Development Table 56. BenchSci Company Information Table 57. BenchSci Business Overview Table 58. BenchSci AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. BenchSci AI Drug Design Product Portfolio Table 60. BenchSci Recent Development Table 61. Antidote Company Information Table 62. Antidote Business Overview Table 63. Antidote AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Antidote AI Drug Design Product Portfolio Table 65. Antidote Recent Development Table 66. AiCure Company Information Table 67. AiCure Business Overview Table 68. AiCure AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. AiCure AI Drug Design Product Portfolio Table 70. AiCure Recent Development Table 71. Atomwise Company Information Table 72. Atomwise Business Overview Table 73. Atomwise AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Atomwise AI Drug Design Product Portfolio Table 75. Atomwise Recent Development Table 76. Envisagenics Company Information Table 77. Envisagenics Business Overview Table 78. Envisagenics AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Envisagenics AI Drug Design Product Portfolio Table 80. Envisagenics Recent Development Table 81. Sherlock Company Information Table 82. Sherlock Business Overview Table 83. Sherlock AI Drug Design Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Sherlock AI Drug Design Product Portfolio Table 85. Sherlock Recent Development Table 86. Deep Genomics Company Information Table 87. Deep Genomics Business Overview Table 88. Deep Genomics AI Drug Design Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Deep Genomics AI Drug Design Product Portfolio Table 90. Deep Genomics Recent Development Table 91. Benevolent Company Information Table 92. Benevolent Business Overview Table 93. Benevolent AI Drug Design Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Benevolent AI Drug Design Product Portfolio Table 95. Benevolent Recent Development Table 96. Iktos Company Information Table 97. Iktos Business Overview Table 98. Iktos AI Drug Design Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Iktos AI Drug Design Product Portfolio Table 100. Iktos Recent Development Table 101. AlmirallShare Company Information Table 102. AlmirallShare Business Overview Table 103. AlmirallShare AI Drug Design Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. AlmirallShare AI Drug Design Product Portfolio Table 105. AlmirallShare Recent Development Table 106. North America AI Drug Design Revenue by Type (2021-2026) & (US$ Million) Table 107. North America AI Drug Design Revenue by Type (2027-2032) & (US$ Million) Table 108. North America AI Drug Design Revenue by Application (2021-2026) & (US$ Million) Table 109. North America AI Drug Design Revenue by Application (2027-2032) & (US$ Million) Table 110. North America AI Drug Design Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America AI Drug Design Revenue by Country (2021-2026) & (US$ Million) Table 112. North America AI Drug Design Revenue by Country (US$ Million) & (2027-2032) Table 113. Europe AI Drug Design Revenue by Type (2021-2026) & (US$ Million) Table 114. Europe AI Drug Design Revenue by Type (2027-2032) & (US$ Million) Table 115. Europe AI Drug Design Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe AI Drug Design Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe AI Drug Design Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe AI Drug Design Revenue by Country (2021-2026) & (US$ Million) Table 119. Europe AI Drug Design Revenue by Country (US$ Million) & (2027-2032) Table 120. China AI Drug Design Revenue by Type (2021-2026) & (US$ Million) Table 121. China AI Drug Design Revenue by Type (2027-2032) & (US$ Million) Table 122. China AI Drug Design Revenue by Application (2021-2026) & (US$ Million) Table 123. China AI Drug Design Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia AI Drug Design Revenue by Type (2021-2026) & (US$ Million) Table 125. Asia AI Drug Design Revenue by Type (2027-2032) & (US$ Million) Table 126. Asia AI Drug Design Revenue by Application (2021-2026) & (US$ Million) Table 127. Asia AI Drug Design Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia AI Drug Design Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Asia AI Drug Design Revenue by Region (US$ Million) & (2021-2026) Table 130. Asia AI Drug Design Revenue by Region (US$ Million) & (2027-2032) Table 131. SAMEA AI Drug Design Revenue by Type (2021-2026) & (US$ Million) Table 132. SAMEA AI Drug Design Revenue by Type (2027-2032) & (US$ Million) Table 133. SAMEA AI Drug Design Revenue by Application (2021-2026) & (US$ Million) Table 134. SAMEA AI Drug Design Revenue by Application (2027-2032) & (US$ Million) Table 135. SAMEA AI Drug Design Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. SAMEA AI Drug Design Revenue by Country (2021-2026) & (US$ Million) Table 137. SAMEA AI Drug Design Revenue by Country (US$ Million) & (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. AI Drug Design Image Figure 2. Global AI Drug Design Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Design Market Size Share 2021 VS 2025 VS 2032 Figure 4. Therapy Research Image Figure 5. Design and Development Image Figure 6. Others Image Figure 7. Global AI Drug Design Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global AI Drug Design Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cancer Image Figure 10. Cardiovascular Disease Image Figure 11. Others Image Figure 12. Global AI Drug Design Market Size (US$ Million) & (2021-2032) Figure 13. Global AI Drug Design Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global AI Drug Design Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global AI Drug Design Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global AI Drug Design Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Drug Design Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global AI Drug Design Revenue Market Share by Type (2021-2032) Figure 20. Global AI Drug Design Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI Drug Design Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global AI Drug Design Revenue Market Share by Application (2021-2032) Figure 23. North America AI Drug Design Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America AI Drug Design Revenue Share by Type (2021-2032) Figure 25. North America AI Drug Design Revenue Share by Application (2021-2032) Figure 26. North America AI Drug Design Revenue Share by Country (2021-2032) Figure 27. United States AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe AI Drug Design Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe AI Drug Design Revenue Share by Type (2021-2032) Figure 32. Europe AI Drug Design Revenue Share by Application (2021-2032) Figure 33. Europe AI Drug Design Revenue Share by Country (2021-2032) Figure 34. Germany AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China AI Drug Design Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China AI Drug Design Revenue Share by Type (2021-2032) Figure 44. China AI Drug Design Revenue Share by Application (2021-2032) Figure 45. Asia AI Drug Design Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia AI Drug Design Revenue Share by Type (2021-2032) Figure 47. Asia AI Drug Design Revenue Share by Application (2021-2032) Figure 48. Asia AI Drug Design Revenue Share by Region (2021-2032) Figure 49. Japan AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA AI Drug Design Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA AI Drug Design Revenue Share by Type (2021-2032) Figure 57. SAMEA AI Drug Design Revenue Share by Application (2021-2032) Figure 58. SAMEA AI Drug Design Revenue Share by Country (2021-2032) Figure 59. Brazil AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt AI Drug Design Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Therapy Research
  • Design and Development
  • Others
Applications
  • Cancer
  • Cardiovascular Disease
  • Others
Companies covered
  • Exscientia
  • PathAI
  • Tempus
  • Aria Pharmaceuticals
  • BenchSci
  • Antidote
  • AiCure
  • Atomwise
  • Envisagenics
  • Sherlock
  • Deep Genomics
  • Benevolent
  • Iktos
  • AlmirallShare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Drug Design Market by Type
  3. 1.2.1 Global AI Drug Design Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Therapy Research
  5. 1.2.3 Design and Development
  6. 1.2.4 Others
  7. 1.3 AI Drug Design Market by Application
  8. 1.3.1 Global AI Drug Design Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer
  10. 1.3.3 Cardiovascular Disease
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 AI Drug Design Market Dynamics
  1. 2.1 AI Drug Design Industry Trends
  2. 2.2 AI Drug Design Industry Drivers
  3. 2.3 AI Drug Design Industry Opportunities and Challenges
  4. 2.4 AI Drug Design Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Drug Design Market Perspective (2021-2032)
  2. 3.2 Global AI Drug Design Growth Trends by Region
  3. 3.2.1 Global AI Drug Design Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Drug Design Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Drug Design Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Drug Design Revenue by Players
  2. 4.1.1 Global AI Drug Design Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Drug Design Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Drug Design Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Drug Design Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Drug Design Key Players Headquarters & Area Served
  7. 4.4 Global AI Drug Design Players, Product Type & Application
  8. 4.5 Global AI Drug Design Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Drug Design Market CR5 and HHI
  11. 4.6.3 2025 AI Drug Design Tier 1, Tier 2, and Tier 3
5 AI Drug Design Market Size by Type
  1. 5.1 Global AI Drug Design Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Design Revenue by Type (2021-2032)
  3. 5.3 Global AI Drug Design Revenue Market Share by Type (2021-2032)
6 AI Drug Design Market Size by Application
  1. 6.1 Global AI Drug Design Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Drug Design Revenue by Application (2021-2032)
  3. 6.3 Global AI Drug Design Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Exscientia
  2. 7.1.1 Exscientia Company Information
  3. 7.1.2 Exscientia Business Overview
  4. 7.1.3 Exscientia AI Drug Design Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Exscientia AI Drug Design Product Portfolio
  6. 7.1.5 Exscientia Recent Developments
  7. 7.2 PathAI
  8. 7.2.1 PathAI Company Information
  9. 7.2.2 PathAI Business Overview
  10. 7.2.3 PathAI AI Drug Design Revenue and Gross Margin (2021-2026)
  11. 7.2.4 PathAI AI Drug Design Product Portfolio
  12. 7.2.5 PathAI Recent Developments
  13. 7.3 Tempus
  14. 7.3.1 Tempus Company Information
  15. 7.3.2 Tempus Business Overview
  16. 7.3.3 Tempus AI Drug Design Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Tempus AI Drug Design Product Portfolio
  18. 7.3.5 Tempus Recent Developments
  19. 7.4 Aria Pharmaceuticals
  20. 7.4.1 Aria Pharmaceuticals Company Information
  21. 7.4.2 Aria Pharmaceuticals Business Overview
  22. 7.4.3 Aria Pharmaceuticals AI Drug Design Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Aria Pharmaceuticals AI Drug Design Product Portfolio
  24. 7.4.5 Aria Pharmaceuticals Recent Developments
  25. 7.5 BenchSci
  26. 7.5.1 BenchSci Company Information
  27. 7.5.2 BenchSci Business Overview
  28. 7.5.3 BenchSci AI Drug Design Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BenchSci AI Drug Design Product Portfolio
  30. 7.5.5 BenchSci Recent Developments
  31. 7.6 Antidote
  32. 7.6.1 Antidote Company Information
  33. 7.6.2 Antidote Business Overview
  34. 7.6.3 Antidote AI Drug Design Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Antidote AI Drug Design Product Portfolio
  36. 7.6.5 Antidote Recent Developments
  37. 7.7 AiCure
  38. 7.7.1 AiCure Company Information
  39. 7.7.2 AiCure Business Overview
  40. 7.7.3 AiCure AI Drug Design Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AiCure AI Drug Design Product Portfolio
  42. 7.7.5 AiCure Recent Developments
  43. 7.8 Atomwise
  44. 7.8.1 Atomwise Company Information
  45. 7.8.2 Atomwise Business Overview
  46. 7.8.3 Atomwise AI Drug Design Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Atomwise AI Drug Design Product Portfolio
  48. 7.8.5 Atomwise Recent Developments
  49. 7.9 Envisagenics
  50. 7.9.1 Envisagenics Company Information
  51. 7.9.2 Envisagenics Business Overview
  52. 7.9.3 Envisagenics AI Drug Design Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Envisagenics AI Drug Design Product Portfolio
  54. 7.9.5 Envisagenics Recent Developments
  55. 7.10 Sherlock
  56. 7.10.1 Sherlock Company Information
  57. 7.10.2 Sherlock Business Overview
  58. 7.10.3 Sherlock AI Drug Design Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sherlock AI Drug Design Product Portfolio
  60. 7.10.5 Sherlock Recent Developments
  61. 7.11 Deep Genomics
  62. 7.11.1 Deep Genomics Company Information
  63. 7.11.2 Deep Genomics Business Overview
  64. 7.11.3 Deep Genomics AI Drug Design Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Deep Genomics AI Drug Design Product Portfolio
  66. 7.11.5 Deep Genomics Recent Developments
  67. 7.12 Benevolent
  68. 7.12.1 Benevolent Company Information
  69. 7.12.2 Benevolent Business Overview
  70. 7.12.3 Benevolent AI Drug Design Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Benevolent AI Drug Design Product Portfolio
  72. 7.12.5 Benevolent Recent Developments
  73. 7.13 Iktos
  74. 7.13.1 Iktos Company Information
  75. 7.13.2 Iktos Business Overview
  76. 7.13.3 Iktos AI Drug Design Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Iktos AI Drug Design Product Portfolio
  78. 7.13.5 Iktos Recent Developments
  79. 7.14 AlmirallShare
  80. 7.14.1 AlmirallShare Company Information
  81. 7.14.2 AlmirallShare Business Overview
  82. 7.14.3 AlmirallShare AI Drug Design Revenue and Gross Margin (2021-2026)
  83. 7.14.4 AlmirallShare AI Drug Design Product Portfolio
  84. 7.14.5 AlmirallShare Recent Developments
8 North America
  1. 8.1 North America AI Drug Design Revenue (2021-2032)
  2. 8.2 North America AI Drug Design Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Drug Design Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Drug Design Revenue by Type (2027-2032)
  5. 8.3 North America AI Drug Design Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Drug Design Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Drug Design Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Drug Design Revenue by Application (2027-2032)
  9. 8.5 North America AI Drug Design Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Drug Design Revenue by Country
  11. 8.6.1 North America AI Drug Design Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Drug Design Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Drug Design Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Drug Design Revenue (2021-2032)
  2. 9.2 Europe AI Drug Design Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Drug Design Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Drug Design Revenue by Type (2027-2032)
  5. 9.3 Europe AI Drug Design Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Drug Design Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Drug Design Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Drug Design Revenue by Application (2027-2032)
  9. 9.5 Europe AI Drug Design Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Drug Design Revenue by Country
  11. 9.6.1 Europe AI Drug Design Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Drug Design Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Drug Design Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Drug Design Revenue (2021-2032)
  2. 10.2 China AI Drug Design Revenue by Type (2021-2032)
  3. 10.2.1 China AI Drug Design Revenue by Type (2021-2026)
  4. 10.2.2 China AI Drug Design Revenue by Type (2027-2032)
  5. 10.3 China AI Drug Design Revenue Share by Type (2021-2032)
  6. 10.4 China AI Drug Design Revenue by Application (2021-2032)
  7. 10.4.1 China AI Drug Design Revenue by Application (2021-2026)
  8. 10.4.2 China AI Drug Design Revenue by Application (2027-2032)
  9. 10.5 China AI Drug Design Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Drug Design Revenue (2021-2032)
  2. 11.2 Asia AI Drug Design Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Drug Design Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Drug Design Revenue by Type (2027-2032)
  5. 11.3 Asia AI Drug Design Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Drug Design Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Drug Design Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Drug Design Revenue by Application (2027-2032)
  9. 11.5 Asia AI Drug Design Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Drug Design Revenue by Country
  11. 11.6.1 Asia AI Drug Design Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Drug Design Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Drug Design Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Drug Design Revenue (2021-2032)
  2. 12.2 SAMEA AI Drug Design Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Drug Design Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Drug Design Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Drug Design Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Drug Design Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Drug Design Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Drug Design Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Drug Design Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Drug Design Revenue by Country
  11. 12.6.1 SAMEA AI Drug Design Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Drug Design Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Drug Design Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst